002118.SZ Stock Analysis
00
Uncovered
Jilin Zixin Pharmaceutical Industrial Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Jilin Zixin Pharmaceutical Industrial Co., Ltd. engages in the research, development, manufacture, and sale of herbal medicines. The company is headquartered in Changchun, Jilin and currently employs 934 full-time employees. The company went IPO on 2007-03-02. The firm operates its businesses through three segments. The Traditional Chinese Patent Drugs segment mainly provides traditional Chinese patent drugs for the treatment of rheumatoid immunity, ear-nose-throat (ENT), urinary system cardiovascular, hepatobiliary and digestive diseases. The Ginseng Products segment is engaged in the provision of deep processing products and rough-wrought products, including white ginseng products, red ginseng products, drinks and candied fruits. The Gene Sequencing segment is engaged in the research and development, manufacture and distribution of gene sequencing machines and supporting reagents.